Rating History for POINT Biopharma Global Inc. (PNT) by Brookline Capital Markets
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/21/2023 | Kemp Dolliver | Downgrade | Hold (Buy) |
12.50 (27.00) |
12.45 (12.50) |
0.4% | Details |
 |
|||||||
|
|||||||
|
|||||||
